February 10, 2026
Headlines

Zhiyi Biotech Reports Successful Phase I Results for SK10 in Chemotherapy-induced Diarrhea Treatment

Editor03 mins

Zhiyi Biotech, a pioneering clinical-stage biotech specializing in live biotherapeutic products (LBPs), has achieved significant milestones with its latest clinical trial results for SK10. The Phase I study, conducted in the United States, has demonstrated promising outcomes in the treatment of chemotherapy-induced diarrhea (CID) using SK10, an innovative heat-killed Bacteroides fragilis product. The randomized, double-blind,…

Read More

Fellos Raises €2.15M to Redefine Men’s Health in the Digital Age

Editor07 mins

In a move that underscores growing momentum in telehealth, Fellos, a digital clinic focused on men’s health, has raised approximately €2.15 million in growth capital. The funding round drew in a cohort of strategic backers, including healthcare professionals, Dutch Operator Fund, and Capital Mills, propelling Fellos further on its mission to make essential men’s health…

Read More

Spear Bio Secures $45 Million in Oversubscribed Series A Round to Revolutionize Protein Research and Diagnostics

Editor04 mins

Spear Bio Inc., an innovative biotechnology company specializing in ultra-sensitive protein detection, has successfully closed an oversubscribed $45 million Series A financing round. The investment was co-led by Foresite Capital and Bio-Techne Corporation, with additional support from Maverick Ventures, Yonjin Capital, and CDH Investments. Vikram Bajaj, Managing Director at Foresite Capital, will join Spear Bio’s…

Read More

Resistant AI’s $25M Bet: Outsmarting the New Age of AI-Driven Financial Crime

Editor08 mins

In an era where criminals use generative AI to forge documents, mimic identities, and exploit financial systems at scale, fraud is no longer a low-tech hustle. It’s a high-tech arms race. Now, Resistant AI, a Prague-based startup, has raised $25 million in Series B funding to fight fire with fire—using artificial intelligence to outsmart AI-powered…

Read More

Rapafusyn Pharmaceuticals Raises $28 Million to Revolutionize Drug Discovery with Innovative Molecular Glue Platform

Editor04 mins

Rapafusyn Pharmaceuticals, a trailblazer in the realm of therapeutic drug discovery, has announced a significant milestone with the closure of a Series A financing round, amassing $28 million. This strategic investment round was led by 3E Bioventures Capital and Proxima Ventures Ltd., with participation from Lapam Capital. Rapafusyn is spearheading the development of non-degrading molecular…

Read More

Balderton Capital Unveils Record €1.1B Fund to Champion Europe’s Next Generation of Tech Innovators

Editor05 mins

In a significant move poised to reshape Europe’s tech landscape, Balderton Capital, the London-based venture capital firm, has announced a monumental $1.3 billion (€1.1 billion) investment package. The firm will deploy this capital through its newly established Early Stage Fund IX, raising $615 million (€563 million), and Growth Fund II, which garnered $685 million (€627…

Read More

InVirtuoLabs Nets €2.85M to Revolutionize Drug Discovery with AI Precision

Editor06 mins

A beacon of innovation has emerged from the serene shores of Lugano, as InVirtuoLabs secures €2.85 million in its inaugural funding round. This Swiss biotech pioneer, dedicated to reshaping the future of pharmaceuticals, is set to harness artificial intelligence to slash the staggering costs and timelines that have long burdened drug development. With this capital,…

Read More

Jobilla Secures €6M to Revolutionize Global Recruitment with AI-Enhanced Localization

Editor06 mins

In a significant boost for the recruitment technology landscape, Jobilla, a leading digital recruitment platform, has announced the successful closure of a €6M funding round. The fresh capital injection, supported by Juuri Partners, Trind VC, Business Finland, business angels, and new Chair of the Board, Matti Vikkula, will propel Jobilla’s international expansion and refine its…

Read More

Orby AI Secures $30 Million Series A Funding to Revolutionize Enterprise Automation

Editor04 mins

Orby AI (Orby), a trailblazer in generative AI solutions for enterprise automation, has announced the successful closure of its series A funding round, raising $30 million from prominent investors. Led by New Enterprise Associates (NEA), Wing VC, and WndrCo, with participation from Pear VC, this funding marks a pivotal moment for Orby. The capital infusion…

Read More

MediView Secures $24 Million to Pioneer a New Era of Augmented Reality in Surgical Navigation

Editor04 mins

MediView XR, Inc., a trailblazer in augmented reality (AR) surgical navigation, announced the successful closure of a $24 million Series A funding round. The round was led by industry giants including GE HealthCare, alongside esteemed healthcare institutions such as Mayo Clinic and Cleveland Clinic, with additional strategic investments from Edge Ventures, Emplify Health’s investment arm,…

Read More